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Background
As cell-based therapies begin to enter clinical trials,
human pluripotent stem cells (PSCs) present a reliable
and robust source of cells for differentiation into all cell
types in the human body [1]. PSC may one day provide
cells for new treatment options for a wide range of dis-
eases including cardiovascular disease, neurodegenera-
tive diseases, and diabetes. The large numbers of cells
required for many of these therapies necessitates the
development of scalable and cost efficient technologies
for manufacturing PSCs and their derivatives [2]. PSCs
are an adherent cell type that is susceptible to phenoty-
pic change in response to environmental stress. Adher-
ent PSCs can be grown in suspension by forming
aggregates of undifferentiated cells [3,4], by encapsulat-
ing PSCs in beads or hydrogels [5,6], or by adhering
PSCs to the surface of microcarriers [7,8].
Most PSC suspension expansion to date has been per-
formed in benchtop stirred-tank bioreactors operating at
volumes of 50-200mL. Little bioprocess optimization
has been conducted at these scales likely because of the
high cost of PSC growth media and labour requirements
for bioreactor growth. This study describes the use of a
small-scale bioreactor system for Design-of-Experiments
based PSC expansion process development. These pro-
cess developments inform strategies to bring PSC-based
processes into clinical production.
Materials and methods
Human embryonic stem cells (HES2 cell line) were cul-
tured in adherent conditions on Geltrex-coated plates.
Cells were fed daily with Nutristem PSC XF Media, and
were passaged with TrypLE every 5-6 days at a passage
ratio of 1:24. Cells were dissociated to single cells for
bioreactor seeding with TrypLE, strained through a 40 μm
strainer, and seeded into Nutristem media with Y-27632
ROCK inhibitor prior to bioreactor seeding. Culture
media was exchanged at regular intervals by allowing
aggregates to settle, removing half of the culture media,
and replacing fresh media (without ROCK inhibitor).
To study the effects of feeding frequency (media
exchange every 1, 2, or 3 days), dissolved oxygen level
(80%, 55%, 30%), and seeding density (2x105, 3x105,
4x105cells/mL) on PSC expansion, a three level, three
factor Box-Behnken experimental design was developed
including three centrepoint replicates (Figure 1a). A
Micro-24 Bioreactor System (Pall) was used with
PRC-Cell Culture cassettes (Figure 1b) and operated with
2mL volume at 7.3 pH, 37°C, and 400rpm. A quadratic
regression model identified the significance of the three
factors, their quadratic effects, and their interaction
effects. Three representative images were captured of cell
aggregates, and aggregate size was determined using the
aggregate size tool in the ImageJ software. Cells were
then dissociated as described above and counted by
Trypan Blue exclusion. Dissociated cells were fixed and
Oct4 and Nanog levels quantified by flow cytometry.
Results
Preliminary results indicated that ROCK inhibitor is essen-
tial for cell survival and expansion (data not shown). Cell
expansion was strongly dependent on feeding frequency
(Figure 1c): daily cell feeding resulted in significantly higher
cell densities. Seeding density also significantly influenced
cell expansion (Figure 1c) with both higher and lower den-
sities producing higher cell expansion than intermediate
densities. The optimal cell density found in this experi-
ment, 2x105cells/mL, was an endpoint within the experi-
mental conditions tested; however, when testing a lower
cell density (1x105 cells/mL), cells formed large aggregates
with low cell viability (data not shown). Fold-increase in
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cell numbers was plotted against the significant input para-
meters (Figure 1d) to depict the surface response in this
experiment. The curvature of the surface response is char-
acteristic of the quadratic parameters that were significant
in the regression of the experimental data. Significant inter-
action effects were observed between seeding density and
feeding frequency (Figure 1c).
The final composition of PSCs in the bioreactor-
expanded cells was quantified by flow cytometry. All
conditions tested retained >90% Oct4+ Nanog+ pluripo-
tent PSCs (representative plot in Figure 1e) after six
days of bioreactor culture.
PSC were observed to spontaneously form uniform
aggregates when seeded into the bioreactor as single
Figure 1 Pluripotent stem cell bioprocess optimization in small scale suspension cultures. (a) Box Behnken Experimental Design. This
experiment used 14 wells of the cassette - 12 wells for points along the edges of the experimental design and 2 centrepoint replicates. This
experimental design allows for the identification of higher-order effects while using fewer than the 24 wells available in the Micro-24 cassette. (b)
Micro-24 Cassette. The PRC-Cell culture cassette with Type A caps is loaded into the Micro-24 system. (c) Significant parameters in quadratic regression
of PSC expansion. Bold factors are significant, including seeding density, feeding, interaction, and quadratic factors of these two parameters. Block
effect was also found to be significant, which indicates variability between passage number of the same cell line. (d) Surface response curve of
significant parameters investigated in the bioreactor expansion of HES2 PSCs. Seeding density and feeding frequency were found to significantly
influence the fold expansion of HES2 cells, with both quadratic and interaction effects between these two parameters also observed. (e)
Representative FACS Plot of PSCs after six days of bioreactor expansion. In all conditions tested, >90% Oct4 Sox2 cell populations were observed. (f)
Relationship between fold expansion and aggregate radius for cells seeded at 2*105 cells/mL. While frequent feeding yields the highest fold expansion
and is correlated to larger final aggregate radius after six days of expansion, it also results in the highest variability in aggregate size. Error bars
represent one standard deviation. (g) Formation and growth of PSC aggregates spontaneously in bioreactor over six days of culture.
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cells, which expanded to uniform PSCs aggregates at 4
and 6 days of expansion (Figure 1f and representative
images in Figure 1g). Aggregate size was found to also be
a function of feeding frequency (Figure 1f), and was cor-
related with final fold increase in cell number. Frequent
feeding resulted in increased variability in aggregate size
(Figure 1f).
Discussion and conclusions
The process optimum found in this study raises several
interesting questions for future experimentation. The
most significant factor was feeding frequency, with more
frequent feeding increasing yields; however, it is unknown
what drives the dramatic effects of media supplementation
on the resultant increased yields. If growth factors are
being depleted, repeating these experiments with culture
media that is more enriched in the necessary growth fac-
tors could generate different trends than those observed
here. Similarly, if secreted factors or metabolites impede
cell growth, modified media exchange strategies may be
appropriate.
While the initial experimental design investigated the
effects of oxygen tension on cell production, this
parameter was found to be insignificant in these studies.
Previous literature indicates that hypoxic conditions are
beneficial for PSC growth [9], as well as the expansion of
various other stem cell types [10,11]. In our experiment,
cells were not previously adapted to hypoxic conditions,
which may impact cell responses during oxygen depen-
dence transitions and limited the observed significance of
this parameter. Alternatively, the dissolved oxygen setpoint
in the hypoxic condition may have been too high to
observe beneficial growth due to differences in mass trans-
fer between the Micro-24 system used and systems used
by others.
For future experimentation, the effects of increasing cul-
ture volume and the resulting effects on the shear stress
that cells are exposed to should be explored. Not only will
this increase understanding of bioprocess parameters in
this platform, but increasing cell volume above the 2 mL
point, which is the low end of the operating range of the
device, could decrease experimental variability.
The Micro-24 system represents a tool useful for
relating media components, cellular parameters, and
bioprocess parameters to cell manufacturing in the cell
therapy industry. The results of this experiment can
guide the development of process design spaces for PSC
expansion processes.
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